FDA inspection
Aurobindo Pharma Limited: FDA inspection ending Feb 21, 2020
FDA inspection 1118385 · Voluntary Action Indicated (VAI) · Medchal
Key facts
| Inspection ID | 1118385 |
|---|---|
| Firm | Aurobindo Pharma Limited |
| FEI number | 3004446312 |
| Address | Unit 12, 314 Survey |
| City | Medchal |
| Country | India |
| Fiscal year | 2020 |
| Inspection end date | Feb 21, 2020 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data